Ovarian cancer is considered a serious illness and a challenge for both doctors and patients. In Argentina, it is estimated that approximately 2,200 women are diagnosed with this disease each year, and unfortunately, 7 out of 10 women reach the diagnosis late. This type of cancer is usually detected in advanced stages, making treatment difficult.
On the occasion of World Ovarian Cancer Day, which is commemorated on May 8, the Argentine Association of Clinical Oncology (AAOC) and the Civil Association Sostén join the global initiative under the slogan #NoWomanLeftBehind. Both organizations warn about the need to increase the available information for the community and promote detection and treatment policies that consider the complexity of this illness.
The diagnosis of ovarian cancer usually occurs when the disease has already spread beyond the ovary. Initial signs, such as abdominal distension, digestive discomfort, pelvic pain, or an immediate feeling of fullness when eating, are often confused with common gastrointestinal or urinary conditions.
'Ovarian cancer is a complex illness, but there is much that can be done about it. Being informed, having regular medical check-ups, and consulting promptly in case of any changes can make a difference,' emphasized a representative of the Civil Association Sostén.
It is essential for women to be aware of persistent changes in their bodies and for health professionals to have a high index of suspicion in the face of certain clinical presentations. Although there is no effective screening test for the general population, early detection remains crucial in managing this disease.
Advances in understanding ovarian cancer have led to the recognition of the genetic component in many cases. The identification of specific biomarkers can indicate a higher risk of developing the disease, allowing for preventive actions and more informed therapeutic decisions.
It is vital for patients to be treated at centers with experience in gynecologic oncology, where they can access appropriate treatments, genetic, nutritional, and emotional counseling, as well as palliative care if necessary.
Genetic information from tumors is essential for making personalized treatment decisions. Innovative and specific therapies are expected to arrive in the coming months to significantly improve the prognosis for patients.
The interdisciplinary approach, surgery, chemotherapy, and targeted therapies are part of the standard approach to ovarian cancer. Although there are challenges, advances in specific therapies offer hope to patients and healthcare teams in the fight against this disease.
